Acute Pain

MONMOUTH JUNCTION, N.J. — September 10, 2026 Adneuris Therapeutics presented new clinical and abuse-potential data for cebranopadol at PAINWeek...

Cambridge, Massachusetts, August 18, 2026 Brixton Biosciences has strengthened its Board of Directors with the appointment of three experienced...

THOUSAND OAKS, Calif., July 29, 2026 Latigo Biotherapeutics announced that The New England Journal of Medicine (NEJM) has published...

RAHWAY, N.J., July 15, 2026 Merck has announced that its blockbuster PD-1 inhibitor KEYTRUDA® (pembrolizumab) achieved the primary endpoint...

CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...

MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...